LAG-3 expression correlates with PD-1 expression on TILs, suggesting implications for postoperative recurrence in non-small-cell lung cancer (NSCLC) and compromised anti-tumor responses in gastric cancer [14,68]. This evidence concerns the gene LAG3 and non-small cell lung carcinoma.